Log In
BCIQ
Print this Print this
 

ch-mAb7F9

  Manage Alerts
Collapse Summary General Information
Company InterveXion Therapeutics LLC
DescriptionChimeric anti-Methamphetamine mAb
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationAddiction
Indication DetailsTreat methamphetamine addiction
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today